DK120337B - Fremgangsmåde til fremstilling af terapeutisk aktive 3-keto-6-halogen-9β10α-Δ<4,6>-steroiddiener af androstan- eller pregnanrækken. - Google Patents

Fremgangsmåde til fremstilling af terapeutisk aktive 3-keto-6-halogen-9β10α-Δ<4,6>-steroiddiener af androstan- eller pregnanrækken.

Info

Publication number
DK120337B
DK120337B DK319165AA DK319165A DK120337B DK 120337 B DK120337 B DK 120337B DK 319165A A DK319165A A DK 319165AA DK 319165 A DK319165 A DK 319165A DK 120337 B DK120337 B DK 120337B
Authority
DK
Denmark
Prior art keywords
androstane
keto
halogen
preparation
therapeutically active
Prior art date
Application number
DK319165AA
Other languages
Danish (da)
English (en)
Inventor
P Westerhof
J Hartog
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB291965A external-priority patent/GB1139411A/en
Priority claimed from CH846564A external-priority patent/CH454842A/de
Application filed by Philips Nv filed Critical Philips Nv
Publication of DK120337B publication Critical patent/DK120337B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK319165AA 1965-01-22 1965-06-23 Fremgangsmåde til fremstilling af terapeutisk aktive 3-keto-6-halogen-9β10α-Δ<4,6>-steroiddiener af androstan- eller pregnanrækken. DK120337B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB291965A GB1139411A (en) 1965-01-22 1965-01-22 Preparation of 10-‡-methyl steroids
CH846564A CH454842A (de) 1965-05-31 1965-05-31 Verfahren zur Herstellung von neuen 9B,10a-Steroiden

Publications (1)

Publication Number Publication Date
DK120337B true DK120337B (da) 1971-05-17

Family

ID=25703347

Family Applications (2)

Application Number Title Priority Date Filing Date
DK319165AA DK120337B (da) 1965-01-22 1965-06-23 Fremgangsmåde til fremstilling af terapeutisk aktive 3-keto-6-halogen-9β10α-Δ<4,6>-steroiddiener af androstan- eller pregnanrækken.
DK324365AA DK123352B (da) 1965-01-22 1965-06-25 Analogifremgangsmåde til fremstilling af 6-halogensubstituerede 9β, 10α-steroider af androstanrækken.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK324365AA DK123352B (da) 1965-01-22 1965-06-25 Analogifremgangsmåde til fremstilling af 6-halogensubstituerede 9β, 10α-steroider af androstanrækken.

Country Status (14)

Country Link
US (2) US3304314A (zh)
AT (1) AT261129B (zh)
BE (2) BE665762A (zh)
BR (1) BR6570589D0 (zh)
CH (1) CH464188A (zh)
DE (2) DE1518994A1 (zh)
DK (2) DK120337B (zh)
ES (1) ES314639A1 (zh)
FI (1) FI41743B (zh)
FR (3) FR4631M (zh)
GB (1) GB1087920A (zh)
IL (2) IL23629A (zh)
NL (2) NL6508148A (zh)
SE (1) SE331277B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE667121A (zh) * 1964-10-28
IL23629A (en) * 1965-01-22 1969-01-29 Hoffmann La Roche 9beta,10alpha-steroids and process for the manufacture thereof
GB1228801A (zh) * 1967-07-11 1971-04-21
US3937700A (en) * 1970-03-04 1976-02-10 U.S. Philips Corporation Novel 1,2-methylene-17α-acyloxy (or improved hydroxy)-9β, 10α-steroid compounds of the pregnane series, pharmaceutic preparations on the basis of the novel compounds and methods of producing said compounds and preparations
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US20070082876A1 (en) * 2005-09-30 2007-04-12 Solvay Pharmaceuticals Gmbh Novel C18 modified retrosteroids as progesterone receptor modulator compounds
US20070212751A1 (en) * 2006-01-18 2007-09-13 Solvay Pharmaceuticals Gmbh Microbial method for the 11beta hydroxylation of 9beta, 10alpha-steriods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL252417A (zh) * 1959-06-08
US3258473A (en) * 1963-10-04 1966-06-28 Syntex Corp 17-dihaloacetate esters of 17alpha-hydroxy-21-desoxypregnane derivatives
IL23629A (en) * 1965-01-22 1969-01-29 Hoffmann La Roche 9beta,10alpha-steroids and process for the manufacture thereof

Also Published As

Publication number Publication date
FR4631M (zh) 1966-11-28
DE1543274A1 (de) 1969-07-24
FR1446515A (fr) 1966-07-22
AT261129B (de) 1968-04-10
US3304314A (en) 1967-02-14
NL6508148A (zh) 1966-06-27
SE331277B (zh) 1970-12-21
US3423433A (en) 1969-01-21
BR6570589D0 (pt) 1973-08-02
DK123352B (da) 1972-06-12
IL23629A (en) 1969-01-29
ES314639A1 (es) 1966-02-16
IL23785A (en) 1969-09-25
FI41743B (zh) 1969-10-31
BE665762A (zh) 1965-12-22
BE666060A (zh) 1965-12-28
FR1439514A (fr) 1966-05-20
CH464188A (de) 1968-10-31
NL6508179A (zh) 1965-12-27
DE1518994A1 (de) 1969-09-25
GB1087920A (en) 1967-10-18

Similar Documents

Publication Publication Date Title
DK116128B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 17α-(alkanoyloxy eller cycloalkanoyloxy)-21-(alkanoyloxy eller cycloalkanoyloxy)-16β-methyl-9α-halogen-11β-hydroxy-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK129835B (da) Analogifremgangsmåde til fremstilling af 2-chlor-6α-fluor-16α-methyl-pregna-1,4-dien-3,20-dioner.
DK129701B (da) Fremgangsmåde til fremstilling af steroider af androstanrækken.
DK116207B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-steroider af pregnanrækken.
DK107871C (da) Fremgangsmåde til fremstilling af 2-alkyl-3-oxo-10α-methylsteroider af androstan- eller pregnanrækken.
DK120337B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 3-keto-6-halogen-9β10α-Δ&lt;4,6&gt;-steroiddiener af androstan- eller pregnanrækken.
DK120190B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive 17-estere af 9α,11β-dihalogen-16α-alkyl-Δ&lt;1,4&gt;-pregnadien-17α,21-diol-3,20-dioner.
DK114060B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 1,2β-metylensteroider af androstan- eller 9-norandrostanrækken.
DK119764B (da) Fremgangsmåde til fremstilling af 3-spiro-3&#39;-diaziridin- eller diazirinsteroider af androstan- eller estranrækken.
DK115472B (da) Fremgangsmåde til fremstilling af 11-hydroxylerede steroider af pregnanrækken.
DK115989B (da) Fremgangsmåde til fremstilling af Δ&lt;5(10)&gt;-3-keto-19-nor-steroider af androstan- og pregnanrækken.
DK126647B (da) Analogifremgangsmåde til fremstilling af 16α,17α-(substitueret-methylen)-steroider af pregnanrækken.
DK124539B (da) Fremgangsmåde til fremstilling af 6-hydroxy-3-keto-Δ&lt;1,4&gt;-steroider af pregnan- eller androstanrækken.
DK103018C (da) Fremgangsmåde til fremstilling af 3-keto-Δ&lt;4,6&gt;-steroider af androstan- eller pregnanrækken.
DK119657B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-21-hydroxy-steroider af pregnanrækken.
DK113146B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 6-halogen-1α,2α-methylen-16α-methyl-&amp;Delta&lt;4,6&gt;-pregnadien-17α-ol-3,20-dioner eller deres 17-estere.
DK113920B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 21-(β-ethoxy-ethoxy)-acetater eller 21-(β-ethoxy-β-ethoxy-ethoxy)-acetater af steroider af pregnanrækken.
DK117350B (da) Fremgangsmåde til fremstilling af 11β-hydroxy-17α-acyloxy-steroider af pregnan-rækken.
DK118461B (da) Fremgangsmåde til fremstilling af 6-halogen- eller -alkylsubstituerede 4-chlor-Δ&lt;4,6&gt;-steroiddiener af androstan- eller pregnanrækken.
DK132226B (da) Fremgangsmåde til fremstilling af 16alfa, 17alfa-dialkylsteroider af pregnanrækken.
DK122452B (da) Analogifremgangsmåde til fremstilling af 21-estere af 6α-halogen-16α-methyl-Δ&lt;1,4&gt;-pregnadien-11β,21-diol-3,20-dioner.
DK124128B (da) Fremgangsmåde til fremstilling af 4-oxo-19-nor-A-homo-Δ&lt;1,5(10)&gt;-steroid-diener af androstan-, pregnan- eller cholestanrækken.
DK132121B (da) Fremgangsmåde til fremstilling af 17alfa-hydroxypregna-4,9(11)-dien-3,20-dion.
DK119554B (da) Fremgangsmåde til fremstilling af 3-keto-Δ&lt;1,4&gt;-steroider af androstan- eller pregnanrækken.
DK101117C (da) Fremgangsmåde til fremstilling af Δ&lt;3,5&gt;-steroider af pregnan-, androstan- eller østranrækken.